Brad Hively Insider Profile
11 Followers
Brad Hively, Director at Starling Oncology Institute, holds 411.98K shares in Starling Oncology Institute (Ticker: STLN). Most recently, Brad Hively Sold 298,853 shares of Starling Oncology Institute on Aug 24, 2026 for an estimated value of $1.95M.
Profitable Transactions
5 out of 8 Profitable Transactions
Average Return
+116.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Brad Hively holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 02, 2024 - Dec 02, 2025
Return:+800.00%
The most profitable trade made by Brad Hively
Brad Hively's Trading History
List of latest transactions for each holding click on a transaction to see Brad Hively's performance on stock
You May Also Like
Brad Hively insider profile FAQ
What is the percentage of profitable transactions made by Brad Hively?
The percentage of profitable transactions made by Brad Hively is 63%.
What is the average return per transaction made by Brad Hively?
The average return per transaction made by Brad Hively is 116.00%.
What stocks does Brad Hively hold?
Brad Hively holds: STLN stocks.
What was Brad Hively’s latest transaction?
Brad Hively latest transaction was an Informative Sell of $1.95M.
What was Brad Hively's most profitable transaction?
Brad Hively’s most profitable transaction was an Informative Buy of STLN stock on December 2, 2024. The return on the trade was 800.00%.
What is Brad Hively's role in Starling Oncology Institute?
Brad Hively's role in Starling Oncology Institute is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.